KILLA EXTRA STRENGTH 4 PACK- salicylic acid patch 
ZitSticka, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

warning

active ingredient

ask a doctor

keep out of reach of children

purpose

dosage

inactive

indications

PDP

KILLA EXTRA STRENGTH 4 PACK 
salicylic acid patch
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:81746-417
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID0.0125 mg  in 0.6216 mg
Inactive Ingredients
Ingredient NameStrength
OLIGOPEPTIDE-10 (UNII: Q46328TRNK)  
GLYCOLIC ACID (UNII: 0WT12SX38S)  
4-BUTYLRESORCINOL (UNII: 2IK4UQ3ZGA)  
HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
NIACINAMIDE (UNII: 25X51I8RD4)  
PHYTOSPHINGOSINE HYDROCHLORIDE (UNII: TT871XV7TU)  
MADECASSOSIDE (UNII: CQ2F5O6YIY)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:81746-417-013660 mg in 1 BOX; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.)01/01/2023
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalM00601/01/2023
Labeler - ZitSticka, Inc. (117778611)
Establishment
NameAddressID/FEIBusiness Operations
Raphas695914964manufacture(81746-417)

Revised: 6/2023
Document Id: fe03b9f5-90b7-b07c-e053-6394a90afac9
Set id: fce9e5fb-2a98-da4f-e053-6294a90ac9ae
Version: 2
Effective Time: 20230613
 
ZitSticka, Inc.